Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Earnings
Avanos sees FY22 adjusted EPS $1.45-$1.65, consensus $1.64 » 07:07
08/09/22
08/09
07:07
08/09/22
07:07
AVNS

Avanos

$28.58 /

-0.2 (-0.69%)

Sees FY22 revenue…

Sees FY22 revenue $815M-$835M, consensus $841.4M.

ShowHide Related Items >><<
AVNS Avanos
$28.58 /

-0.2 (-0.69%)

07/18/22 Stifel
Avanos price target lowered to $28 from $37 at Stifel
02/24/22 KeyBanc
Avanos price target lowered to $41 from $47 at KeyBanc
AVNS Avanos
$28.58 /

-0.2 (-0.69%)

Earnings
Avanos reports Q2 adjusted EPS 41c, consensus 38c » 07:06
08/09/22
08/09
07:06
08/09/22
07:06
AVNS

Avanos

$28.58 /

-0.2 (-0.69%)

Reports Q2 revenue $203M,…

Reports Q2 revenue $203M, consensus $208.27M.

ShowHide Related Items >><<
AVNS Avanos
$28.58 /

-0.2 (-0.69%)

07/18/22 Stifel
Avanos price target lowered to $28 from $37 at Stifel
02/24/22 KeyBanc
Avanos price target lowered to $41 from $47 at KeyBanc
AVNS Avanos
$28.58 /

-0.2 (-0.69%)

Recommendations
Avanos price target lowered to $28 from $37 at Stifel » 07:34
07/18/22
07/18
07:34
07/18/22
07:34
AVNS

Avanos

$26.84 /

+0.44 (+1.67%)

Stifel analyst Rick Wise…

Stifel analyst Rick Wise lowered the firm's price target on Avanos to $28 from $37 and keeps a Hold rating on the shares. Many of his targets had been based on multiples assigned well-before multiple economic and geopolitical headwinds pushed both market- and industry-wide share prices lower and he is adjusting his MedTech trading multiples ahead of Q2 earnings season, though Wise notes that his target changes "do not represent any fundamental shift in our positive long-term thinking for the MedTech industry or the potential for broad-based growth reacceleration."

ShowHide Related Items >><<
AVNS Avanos
$26.84 /

+0.44 (+1.67%)

02/24/22 KeyBanc
Avanos price target lowered to $41 from $47 at KeyBanc
08/04/21 KeyBanc
Avanos price target lowered to $47 from $55 at KeyBanc
08/04/21 Stephens
Avanos downgraded to Equal Weight from Overweight at Stephens
AVNS Avanos
$26.84 /

+0.44 (+1.67%)

Over a quarter ago
Earnings
Avanos backs FY22 adjusted EPS view $1.55-$1.75, consensus $1.64 » 07:06
05/04/22
05/04
07:06
05/04/22
07:06
AVNS

Avanos

$29.15 /

-0.055 (-0.19%)

Backs FY22 revenue view…

Backs FY22 revenue view $830M-$850M, consensus $842.09M.

ShowHide Related Items >><<
AVNS Avanos
$29.15 /

-0.055 (-0.19%)

AVNS Avanos
$29.15 /

-0.055 (-0.19%)

02/24/22 KeyBanc
Avanos price target lowered to $41 from $47 at KeyBanc
08/04/21 KeyBanc
Avanos price target lowered to $47 from $55 at KeyBanc
08/04/21 Stephens
Avanos downgraded to Equal Weight from Overweight at Stephens
AVNS Avanos
$29.15 /

-0.055 (-0.19%)

Earnings
Avanos reports Q1 adjusted EPS 26c, consensus 26c » 07:05
05/04/22
05/04
07:05
05/04/22
07:05
AVNS

Avanos

$29.15 /

-0.055 (-0.19%)

Reports Q1 revenue $197M,…

Reports Q1 revenue $197M, consensus $197.8M.

ShowHide Related Items >><<
AVNS Avanos
$29.15 /

-0.055 (-0.19%)

AVNS Avanos
$29.15 /

-0.055 (-0.19%)

02/24/22 KeyBanc
Avanos price target lowered to $41 from $47 at KeyBanc
08/04/21 KeyBanc
Avanos price target lowered to $47 from $55 at KeyBanc
08/04/21 Stephens
Avanos downgraded to Equal Weight from Overweight at Stephens
AVNS Avanos
$29.15 /

-0.055 (-0.19%)

Conference/Events
KeyBanc to hold a virtual forum » 04:55
03/23/22
03/23
04:55
03/23/22
04:55
AGTI

Agiliti

$20.24 /

+0.41 (+2.07%)

, AMWL

Amwell

$3.97 /

+0.145 (+3.80%)

, ANGO

AngioDynamics

$22.71 /

-0.44 (-1.90%)

, AVNS

Avanos

$32.46 /

+0.51 (+1.60%)

, AVTR

Avantor

$34.73 /

+0.245 (+0.71%)

, AZTA

Azenta

$86.72 /

+0.19 (+0.22%)

, BLFS

BioLife Solutions

$23.18 /

+0.335 (+1.47%)

, CSTL

Castle Biosciences

$45.89 /

+2.68 (+6.20%)

, EBS

Emergent BioSolutions

$42.52 /

+1.03 (+2.48%)

, ENZ

Enzo Biochem

$3.04 /

+0.04 (+1.33%)

, EVH

Evolent Health

$31.91 /

+0.55 (+1.75%)

, ICUI

ICU Medical

$242.89 /

-4.85 (-1.96%)

, INGN

Inogen

$33.31 /

+0.1 (+0.30%)

, IVC

Invacare

$1.60 /

+0.01 (+0.63%)

, LMAT

LeMaitre

$45.32 /

+1.54 (+3.52%)

, MRVI

Maravai Lifesciences

$38.84 /

+0.34 (+0.88%)

, NXGN

NextGen Healthcare

$20.31 /

+0.15 (+0.74%)

, PINC

Premier

$35.90 /

+0.07 (+0.20%)

, TFX

Teleflex

$346.65 /

-0.61 (-0.18%)

, WST

West Pharmaceutical

$413.43 /

+0.93 (+0.23%)

, XGN

Exagen

$8.25 /

+0.21 (+2.61%)

Life Sciences &…

Life Sciences & MedTech Virtual Forum to be held on March 22-23.

ShowHide Related Items >><<
XGN Exagen
$8.25 /

+0.21 (+2.61%)

WST West Pharmaceutical
$413.43 /

+0.93 (+0.23%)

TFX Teleflex
$346.65 /

-0.61 (-0.18%)

PINC Premier
$35.90 /

+0.07 (+0.20%)

NXGN NextGen Healthcare
$20.31 /

+0.15 (+0.74%)

MRVI Maravai Lifesciences
$38.84 /

+0.34 (+0.88%)

LMAT LeMaitre
$45.32 /

+1.54 (+3.52%)

IVC Invacare
$1.60 /

+0.01 (+0.63%)

INGN Inogen
$33.31 /

+0.1 (+0.30%)

EVH Evolent Health
$31.91 /

+0.55 (+1.75%)

ENZ Enzo Biochem
$3.04 /

+0.04 (+1.33%)

EBS Emergent BioSolutions
$42.52 /

+1.03 (+2.48%)

CSTL Castle Biosciences
$45.89 /

+2.68 (+6.20%)

BLFS BioLife Solutions
$23.18 /

+0.335 (+1.47%)

AZTA Azenta
$86.72 /

+0.19 (+0.22%)

AVTR Avantor
$34.73 /

+0.245 (+0.71%)

AVNS Avanos
$32.46 /

+0.51 (+1.60%)

ANGO AngioDynamics
$22.71 /

-0.44 (-1.90%)

AGTI Agiliti
$20.24 /

+0.41 (+2.07%)

03/09/22 Citi
Agiliti price target lowered to $25 from $28 at Citi
01/10/22 Citi
Agiliti assumed with a Buy at Citi
08/16/21 Citi
Citi says Agiliti selloff overdone, boosts target to $22
05/26/21 BMO Capital
Agiliti price target raised to $26 from $18 at BMO Capital
AMWL Amwell
$3.97 /

+0.145 (+3.80%)

02/25/22 Piper Sandler
Amwell price target lowered to $7 from $12 at Piper Sandler
02/11/22 Goldman Sachs
Amwell initiated with a Neutral at Goldman Sachs
12/01/21 Jefferies
Amwell initiated with a Hold at Jefferies
11/22/21 Piper Sandler
Piper remains buyer of Amwell despite chat supporting below consensus FY22 view
ANGO AngioDynamics
$22.71 /

-0.44 (-1.90%)

01/07/22 Canaccord
AngioDynamics price target lowered to $34 from $37 at Canaccord
10/15/21
Fly Intel: Top five analyst upgrades
10/15/21 Canaccord
AngioDynamics upgraded to Buy at Canaccord on future growth clarity
10/15/21 Canaccord
AngioDynamics upgraded to Buy from Hold at Canaccord
AVNS Avanos
$32.46 /

+0.51 (+1.60%)

02/24/22 KeyBanc
Avanos price target lowered to $41 from $47 at KeyBanc
08/04/21 KeyBanc
Avanos price target lowered to $47 from $55 at KeyBanc
08/04/21 Stephens
Avanos downgraded to Equal Weight from Overweight at Stephens
AVTR Avantor
$34.73 /

+0.245 (+0.71%)

02/07/22 Raymond James
Avantor price target lowered to $43 from $47 at Raymond James
02/07/22 Baird
Avantor price target lowered to $43 from $44 at Baird
02/07/22 Barclays
Avantor price target raised to $44 from $41 at Barclays
01/27/22 Barclays
Avantor price target lowered to $41 from $48 at Barclays
AZTA Azenta
$86.72 /

+0.19 (+0.22%)

03/21/22 Evercore ISI
Azenta initiated with an Outperform at Evercore ISI
02/09/22 Needham
Azenta price target lowered to $115 from $155 at Needham
11/17/21 Stifel
Brooks Automation price target raised to $149 from $134 at Stifel
11/17/21 Stephens
Brooks Automation price target raised to $137 from $130 at Stephens
BLFS BioLife Solutions
$23.18 /

+0.335 (+1.47%)

03/02/22 B. Riley
BioLife Solutions price target lowered to $48 from $67 at B. Riley
01/03/22 Stephens
Wendy's, Kirby and Vizio among Stephens' 2022 Best Ideas
12/31/21 Northland
BioLife Solutions named a top pick for 2022 at Northland
10/19/21 B. Riley
BioLife Solutions transferred with Buy, $61 target at B. Riley
CSTL Castle Biosciences
$45.89 /

+2.68 (+6.20%)

03/01/22 Lake Street
Castle Biosciences price target lowered to $63 from $94 at Lake Street
03/01/22 Baird
Castle Biosciences price target lowered to $60 from $82 at Baird
01/06/22 Stephens
Stephens starts skin cancer test leader Castle Biosciences at Overweight
01/06/22 Stephens
Castle Biosciences initiated with an Overweight at Stephens
EBS Emergent BioSolutions
$42.52 /

+1.03 (+2.48%)

01/20/22 Cantor Fitzgerald
Emergent BioSolutions price target raised to $55 from $50 at Cantor Fitzgerald
01/20/22 Benchmark
Emergent BioSolutions upgraded to Buy from Hold at Benchmark
12/27/21 Cowen
Emergent's Narcan sales under immediate threat, says Cowen
11/10/21 Chardan
Emergent BioSolutions price target lowered to $75 from $92 at Chardan
ENZ Enzo Biochem
$3.04 /

+0.04 (+1.33%)

EVH Evolent Health
$31.91 /

+0.55 (+1.75%)

03/08/22 Cowen
Evolent Health remains top pick after meeting with management, says Cowen
03/07/22 Piper Sandler
Evolent Health news removes $82M overhang, says Piper Sandler
03/04/22 Piper Sandler
Bright Health expansion big revenue opportunity for Evolent, says Piper
02/24/22 Piper Sandler
Evolent Health price target lowered to $32 from $36 at Piper Sandler
ICUI ICU Medical
$242.89 /

-4.85 (-1.96%)

09/09/21 Raymond James
ICU Medical price target raised to $286 from $220 at Raymond James
INGN Inogen
$33.31 /

+0.1 (+0.30%)

12/09/21 Needham
Inogen upgraded to Buy from Hold at Needham
12/09/21 Needham
Inogen upgraded to Buy from Hold at Needham
11/02/21
Fly Intel: Top five analyst upgrades
11/02/21 JPMorgan
Inogen upgraded to Neutral with risks priced in at JPMorgan
IVC Invacare
$1.60 /

+0.01 (+0.63%)

09/10/21 Needham
Invacare price target lowered to $8 from $17 at Needham
08/19/21 Oppenheimer
Invacare initiated with an Outperform at Oppenheimer
LMAT LeMaitre
$45.32 /

+1.54 (+3.52%)

02/25/22 Barrington
LeMaitre price target lowered to $54 from $62 at Barrington
09/16/21
Fly Intel: Top five analyst initiations
09/16/21 Jefferies
Jefferies starts LeMaitre at Buy on ArteGraft upside potential
09/16/21 Jefferies
LeMaitre initiated with a Buy at Jefferies
MRVI Maravai Lifesciences
$38.84 /

+0.34 (+0.88%)

02/28/22 William Blair
Maravai buyout price would need to be well into $50s, says William Blair
02/24/22 Baird
Maravai Lifesciences price target lowered to $48 from $60 at Baird
10/01/21 Morgan Stanley
Maravai selloff on Merck's molnupiravir data overdone, says Morgan Stanley
08/11/21 Credit Suisse
Maravai Lifesciences price target raised to $54 from $44 at Credit Suisse
NXGN NextGen Healthcare
$20.31 /

+0.15 (+0.74%)

01/26/22 Piper Sandler
NextGen Healthcare price target raised to $24 from $23 at Piper Sandler
01/06/22 SVB Securities
SVB Leerink upgrades NextGen Healthcare to Outperform with $22 price target
01/06/22 SVB Securities
NextGen Healthcare upgraded to Outperform from Market Perform at SVB Leerink
01/05/22 Piper Sandler
NextGen Healthcare named a 2022 top pick at Piper Sandler
PINC Premier
$35.90 /

+0.07 (+0.20%)

11/18/21 Barclays
Premier price target raised to $36 from $34 at Barclays
11/03/21 Piper Sandler
Premier price target raised to $39 from $31 at Piper Sandler
05/28/21
Fly Intel: Top five analyst downgrades
05/28/21 Barclays
Barclays double downgrades Premier with multiple expansion less likely
TFX Teleflex
$346.65 /

-0.61 (-0.18%)

02/24/22 Piper Sandler
Teleflex price target raised to $335 from $320 at Piper Sandler
01/21/22 Piper Sandler
Teleflex price target lowered to $320 from $325 at Piper Sandler
01/07/22 Morgan Stanley
Teleflex cut to Equal Weight at Morgan Stanley on near-term UroLift caution
01/07/22 Morgan Stanley
Teleflex downgraded to Equal Weight from Overweight at Morgan Stanley
WST West Pharmaceutical
$413.43 /

+0.93 (+0.23%)

XGN Exagen
$8.25 /

+0.21 (+2.61%)

10/14/21 Cowen
Exagen coverage transferred at Cowen
08/10/21 BTIG
Exagen price target lowered to $20 from $23 at BTIG
04/15/21
Fly Intel: Top five analyst initiations
04/15/21 Canaccord
Canaccord starts Exagen at Buy, sees 50% upside potential
XGN Exagen
$8.25 /

+0.21 (+2.61%)

WST West Pharmaceutical
$413.43 /

+0.93 (+0.23%)

TFX Teleflex
$346.65 /

-0.61 (-0.18%)

PINC Premier
$35.90 /

+0.07 (+0.20%)

NXGN NextGen Healthcare
$20.31 /

+0.15 (+0.74%)

MRVI Maravai Lifesciences
$38.84 /

+0.34 (+0.88%)

LMAT LeMaitre
$45.32 /

+1.54 (+3.52%)

IVC Invacare
$1.60 /

+0.01 (+0.63%)

INGN Inogen
$33.31 /

+0.1 (+0.30%)

ICUI ICU Medical
$242.89 /

-4.85 (-1.96%)

EVH Evolent Health
$31.91 /

+0.55 (+1.75%)

ENZ Enzo Biochem
$3.04 /

+0.04 (+1.33%)

EBS Emergent BioSolutions
$42.52 /

+1.03 (+2.48%)

CSTL Castle Biosciences
$45.89 /

+2.68 (+6.20%)

BLFS BioLife Solutions
$23.18 /

+0.335 (+1.47%)

AZTA Azenta
$86.72 /

+0.19 (+0.22%)

AVTR Avantor
$34.73 /

+0.245 (+0.71%)

AVNS Avanos
$32.46 /

+0.51 (+1.60%)

ANGO AngioDynamics
$22.71 /

-0.44 (-1.90%)

AMWL Amwell
$3.97 /

+0.145 (+3.80%)

AGTI Agiliti
$20.24 /

+0.41 (+2.07%)

  • 14
    Sep
  • 10
    Sep
  • 14
    Jul
  • 23
    Apr
  • 08
    Apr
MRVI Maravai Lifesciences
$38.84 /

+0.34 (+0.88%)

EVH Evolent Health
$31.91 /

+0.55 (+1.75%)

EBS Emergent BioSolutions
$42.52 /

+1.03 (+2.48%)

AMWL Amwell
$3.97 /

+0.145 (+3.80%)

XGN Exagen
$8.25 /

+0.21 (+2.61%)

TFX Teleflex
$346.65 /

-0.61 (-0.18%)

MRVI Maravai Lifesciences
$38.84 /

+0.34 (+0.88%)

EVH Evolent Health
$31.91 /

+0.55 (+1.75%)

EBS Emergent BioSolutions
$42.52 /

+1.03 (+2.48%)

BLFS BioLife Solutions
$23.18 /

+0.335 (+1.47%)

AZTA Azenta
$86.72 /

+0.19 (+0.22%)

AVTR Avantor
$34.73 /

+0.245 (+0.71%)

ANGO AngioDynamics
$22.71 /

-0.44 (-1.90%)

AMWL Amwell
$3.97 /

+0.145 (+3.80%)

AGTI Agiliti
$20.24 /

+0.41 (+2.07%)

WST West Pharmaceutical
$413.43 /

+0.93 (+0.23%)

IVC Invacare
$1.60 /

+0.01 (+0.63%)

ENZ Enzo Biochem
$3.04 /

+0.04 (+1.33%)

AZTA Azenta
$86.72 /

+0.19 (+0.22%)

AMWL Amwell
$3.97 /

+0.145 (+3.80%)

Conference/Events
KeyBanc to hold a virtual forum » 04:55
03/22/22
03/22
04:55
03/22/22
04:55
AGTI

Agiliti

$19.82 /

+0.8 (+4.21%)

, AMWL

Amwell

$3.82 /

-0.13 (-3.29%)

, ANGO

AngioDynamics

$23.05 /

-0.91 (-3.80%)

, AVNS

Avanos

$32.09 /

-0.415 (-1.28%)

, AVTR

Avantor

$34.49 /

-0.655 (-1.86%)

, AZTA

Azenta

$86.50 /

-0.82 (-0.94%)

, BLFS

BioLife Solutions

$22.98 /

-1.63 (-6.62%)

, CSTL

Castle Biosciences

$43.62 /

-1.41 (-3.13%)

, EBS

Emergent BioSolutions

$41.42 /

-1.5 (-3.49%)

, ENZ

Enzo Biochem

$3.00 /

-0.08 (-2.60%)

, EVH

Evolent Health

$31.34 /

+0.495 (+1.60%)

, ICUI

ICU Medical

$247.68 /

+2.9 (+1.18%)

, INGN

Inogen

$33.42 /

+0.15 (+0.45%)

, IVC

Invacare

$1.59 /

-0.13 (-7.56%)

, LMAT

LeMaitre

$44.15 /

-1.91 (-4.15%)

, MRVI

Maravai Lifesciences

$38.50 /

-2.28 (-5.59%)

, NXGN

NextGen Healthcare

$20.16 /

+0.35 (+1.77%)

, PINC

Premier

$35.85 /

-0.51 (-1.40%)

, TFX

Teleflex

$349.16 /

-1.02 (-0.29%)

, WST

West Pharmaceutical

$412.49 /

-1.72 (-0.42%)

, XGN

Exagen

$8.15 /

-0.33 (-3.89%)

Life Sciences &…

Life Sciences & MedTech Virtual Forum to be held on March 22-23.

ShowHide Related Items >><<
XGN Exagen
$8.15 /

-0.33 (-3.89%)

WST West Pharmaceutical
$412.49 /

-1.72 (-0.42%)

TFX Teleflex
$349.16 /

-1.02 (-0.29%)

PINC Premier
$35.85 /

-0.51 (-1.40%)

NXGN NextGen Healthcare
$20.16 /

+0.35 (+1.77%)

MRVI Maravai Lifesciences
$38.50 /

-2.28 (-5.59%)

LMAT LeMaitre
$44.15 /

-1.91 (-4.15%)

IVC Invacare
$1.59 /

-0.13 (-7.56%)

INGN Inogen
$33.42 /

+0.15 (+0.45%)

EVH Evolent Health
$31.34 /

+0.495 (+1.60%)

ENZ Enzo Biochem
$3.00 /

-0.08 (-2.60%)

EBS Emergent BioSolutions
$41.42 /

-1.5 (-3.49%)

CSTL Castle Biosciences
$43.62 /

-1.41 (-3.13%)

BLFS BioLife Solutions
$22.98 /

-1.63 (-6.62%)

AZTA Azenta
$86.50 /

-0.82 (-0.94%)

AVTR Avantor
$34.49 /

-0.655 (-1.86%)

AVNS Avanos
$32.09 /

-0.415 (-1.28%)

ANGO AngioDynamics
$23.05 /

-0.91 (-3.80%)

AGTI Agiliti
$19.82 /

+0.8 (+4.21%)

03/09/22 Citi
Agiliti price target lowered to $25 from $28 at Citi
01/10/22 Citi
Agiliti assumed with a Buy at Citi
08/16/21 Citi
Citi says Agiliti selloff overdone, boosts target to $22
05/26/21 BMO Capital
Agiliti price target raised to $26 from $18 at BMO Capital
AMWL Amwell
$3.82 /

-0.13 (-3.29%)

02/25/22 Piper Sandler
Amwell price target lowered to $7 from $12 at Piper Sandler
02/11/22 Goldman Sachs
Amwell initiated with a Neutral at Goldman Sachs
12/01/21 Jefferies
Amwell initiated with a Hold at Jefferies
11/22/21 Piper Sandler
Piper remains buyer of Amwell despite chat supporting below consensus FY22 view
ANGO AngioDynamics
$23.05 /

-0.91 (-3.80%)

01/07/22 Canaccord
AngioDynamics price target lowered to $34 from $37 at Canaccord
10/15/21
Fly Intel: Top five analyst upgrades
10/15/21 Canaccord
AngioDynamics upgraded to Buy at Canaccord on future growth clarity
10/15/21 Canaccord
AngioDynamics upgraded to Buy from Hold at Canaccord
AVNS Avanos
$32.09 /

-0.415 (-1.28%)

02/24/22 KeyBanc
Avanos price target lowered to $41 from $47 at KeyBanc
08/04/21 KeyBanc
Avanos price target lowered to $47 from $55 at KeyBanc
08/04/21 Stephens
Avanos downgraded to Equal Weight from Overweight at Stephens
AVTR Avantor
$34.49 /

-0.655 (-1.86%)

02/07/22 Raymond James
Avantor price target lowered to $43 from $47 at Raymond James
02/07/22 Baird
Avantor price target lowered to $43 from $44 at Baird
02/07/22 Barclays
Avantor price target raised to $44 from $41 at Barclays
01/27/22 Barclays
Avantor price target lowered to $41 from $48 at Barclays
AZTA Azenta
$86.50 /

-0.82 (-0.94%)

03/21/22 Evercore ISI
Azenta initiated with an Outperform at Evercore ISI
02/09/22 Needham
Azenta price target lowered to $115 from $155 at Needham
11/17/21 Stifel
Brooks Automation price target raised to $149 from $134 at Stifel
11/17/21 Stephens
Brooks Automation price target raised to $137 from $130 at Stephens
BLFS BioLife Solutions
$22.98 /

-1.63 (-6.62%)

03/02/22 B. Riley
BioLife Solutions price target lowered to $48 from $67 at B. Riley
01/03/22 Stephens
Wendy's, Kirby and Vizio among Stephens' 2022 Best Ideas
12/31/21 Northland
BioLife Solutions named a top pick for 2022 at Northland
10/19/21 B. Riley
BioLife Solutions transferred with Buy, $61 target at B. Riley
CSTL Castle Biosciences
$43.62 /

-1.41 (-3.13%)

03/01/22 Lake Street
Castle Biosciences price target lowered to $63 from $94 at Lake Street
03/01/22 Baird
Castle Biosciences price target lowered to $60 from $82 at Baird
01/06/22 Stephens
Stephens starts skin cancer test leader Castle Biosciences at Overweight
01/06/22 Stephens
Castle Biosciences initiated with an Overweight at Stephens
EBS Emergent BioSolutions
$41.42 /

-1.5 (-3.49%)

01/20/22 Cantor Fitzgerald
Emergent BioSolutions price target raised to $55 from $50 at Cantor Fitzgerald
01/20/22 Benchmark
Emergent BioSolutions upgraded to Buy from Hold at Benchmark
12/27/21 Cowen
Emergent's Narcan sales under immediate threat, says Cowen
11/10/21 Chardan
Emergent BioSolutions price target lowered to $75 from $92 at Chardan
ENZ Enzo Biochem
$3.00 /

-0.08 (-2.60%)

EVH Evolent Health
$31.34 /

+0.495 (+1.60%)

03/08/22 Cowen
Evolent Health remains top pick after meeting with management, says Cowen
03/07/22 Piper Sandler
Evolent Health news removes $82M overhang, says Piper Sandler
03/04/22 Piper Sandler
Bright Health expansion big revenue opportunity for Evolent, says Piper
02/24/22 Piper Sandler
Evolent Health price target lowered to $32 from $36 at Piper Sandler
ICUI ICU Medical
$247.68 /

+2.9 (+1.18%)

09/09/21 Raymond James
ICU Medical price target raised to $286 from $220 at Raymond James
INGN Inogen
$33.42 /

+0.15 (+0.45%)

12/09/21 Needham
Inogen upgraded to Buy from Hold at Needham
12/09/21 Needham
Inogen upgraded to Buy from Hold at Needham
11/02/21
Fly Intel: Top five analyst upgrades
11/02/21 JPMorgan
Inogen upgraded to Neutral with risks priced in at JPMorgan
IVC Invacare
$1.59 /

-0.13 (-7.56%)

09/10/21 Needham
Invacare price target lowered to $8 from $17 at Needham
08/19/21 Oppenheimer
Invacare initiated with an Outperform at Oppenheimer
LMAT LeMaitre
$44.15 /

-1.91 (-4.15%)

02/25/22 Barrington
LeMaitre price target lowered to $54 from $62 at Barrington
09/16/21
Fly Intel: Top five analyst initiations
09/16/21 Jefferies
Jefferies starts LeMaitre at Buy on ArteGraft upside potential
09/16/21 Jefferies
LeMaitre initiated with a Buy at Jefferies
MRVI Maravai Lifesciences
$38.50 /

-2.28 (-5.59%)

02/28/22 William Blair
Maravai buyout price would need to be well into $50s, says William Blair
02/24/22 Baird
Maravai Lifesciences price target lowered to $48 from $60 at Baird
10/01/21 Morgan Stanley
Maravai selloff on Merck's molnupiravir data overdone, says Morgan Stanley
08/11/21 Credit Suisse
Maravai Lifesciences price target raised to $54 from $44 at Credit Suisse
NXGN NextGen Healthcare
$20.16 /

+0.35 (+1.77%)

01/26/22 Piper Sandler
NextGen Healthcare price target raised to $24 from $23 at Piper Sandler
01/06/22 SVB Securities
SVB Leerink upgrades NextGen Healthcare to Outperform with $22 price target
01/06/22 SVB Securities
NextGen Healthcare upgraded to Outperform from Market Perform at SVB Leerink
01/05/22 Piper Sandler
NextGen Healthcare named a 2022 top pick at Piper Sandler
PINC Premier
$35.85 /

-0.51 (-1.40%)

11/18/21 Barclays
Premier price target raised to $36 from $34 at Barclays
11/03/21 Piper Sandler
Premier price target raised to $39 from $31 at Piper Sandler
05/28/21
Fly Intel: Top five analyst downgrades
05/28/21 Barclays
Barclays double downgrades Premier with multiple expansion less likely
TFX Teleflex
$349.16 /

-1.02 (-0.29%)

02/24/22 Piper Sandler
Teleflex price target raised to $335 from $320 at Piper Sandler
01/21/22 Piper Sandler
Teleflex price target lowered to $320 from $325 at Piper Sandler
01/07/22 Morgan Stanley
Teleflex cut to Equal Weight at Morgan Stanley on near-term UroLift caution
01/07/22 Morgan Stanley
Teleflex downgraded to Equal Weight from Overweight at Morgan Stanley
WST West Pharmaceutical
$412.49 /

-1.72 (-0.42%)

XGN Exagen
$8.15 /

-0.33 (-3.89%)

10/14/21 Cowen
Exagen coverage transferred at Cowen
08/10/21 BTIG
Exagen price target lowered to $20 from $23 at BTIG
04/15/21
Fly Intel: Top five analyst initiations
04/15/21 Canaccord
Canaccord starts Exagen at Buy, sees 50% upside potential
XGN Exagen
$8.15 /

-0.33 (-3.89%)

WST West Pharmaceutical
$412.49 /

-1.72 (-0.42%)

TFX Teleflex
$349.16 /

-1.02 (-0.29%)

PINC Premier
$35.85 /

-0.51 (-1.40%)

NXGN NextGen Healthcare
$20.16 /

+0.35 (+1.77%)

MRVI Maravai Lifesciences
$38.50 /

-2.28 (-5.59%)

LMAT LeMaitre
$44.15 /

-1.91 (-4.15%)

IVC Invacare
$1.59 /

-0.13 (-7.56%)

INGN Inogen
$33.42 /

+0.15 (+0.45%)

ICUI ICU Medical
$247.68 /

+2.9 (+1.18%)

EVH Evolent Health
$31.34 /

+0.495 (+1.60%)

ENZ Enzo Biochem
$3.00 /

-0.08 (-2.60%)

EBS Emergent BioSolutions
$41.42 /

-1.5 (-3.49%)

CSTL Castle Biosciences
$43.62 /

-1.41 (-3.13%)

BLFS BioLife Solutions
$22.98 /

-1.63 (-6.62%)

AZTA Azenta
$86.50 /

-0.82 (-0.94%)

AVTR Avantor
$34.49 /

-0.655 (-1.86%)

AVNS Avanos
$32.09 /

-0.415 (-1.28%)

ANGO AngioDynamics
$23.05 /

-0.91 (-3.80%)

AMWL Amwell
$3.82 /

-0.13 (-3.29%)

AGTI Agiliti
$19.82 /

+0.8 (+4.21%)

  • 14
    Sep
  • 10
    Sep
  • 14
    Jul
  • 23
    Apr
  • 08
    Apr
  • 23
    Mar
MRVI Maravai Lifesciences
$38.50 /

-2.28 (-5.59%)

EVH Evolent Health
$31.34 /

+0.495 (+1.60%)

EBS Emergent BioSolutions
$41.42 /

-1.5 (-3.49%)

AMWL Amwell
$3.82 /

-0.13 (-3.29%)

TFX Teleflex
$349.16 /

-1.02 (-0.29%)

MRVI Maravai Lifesciences
$38.50 /

-2.28 (-5.59%)

EVH Evolent Health
$31.34 /

+0.495 (+1.60%)

EBS Emergent BioSolutions
$41.42 /

-1.5 (-3.49%)

BLFS BioLife Solutions
$22.98 /

-1.63 (-6.62%)

AZTA Azenta
$86.50 /

-0.82 (-0.94%)

AVTR Avantor
$34.49 /

-0.655 (-1.86%)

ANGO AngioDynamics
$23.05 /

-0.91 (-3.80%)

AMWL Amwell
$3.82 /

-0.13 (-3.29%)

AGTI Agiliti
$19.82 /

+0.8 (+4.21%)

WST West Pharmaceutical
$412.49 /

-1.72 (-0.42%)

IVC Invacare
$1.59 /

-0.13 (-7.56%)

ENZ Enzo Biochem
$3.00 /

-0.08 (-2.60%)

AZTA Azenta
$86.50 /

-0.82 (-0.94%)

AMWL Amwell
$3.82 /

-0.13 (-3.29%)

Conference/Events
KeyBanc to hold a virtual forum » 17:05
03/21/22
03/21
17:05
03/21/22
17:05
AGTI

Agiliti

$19.82 /

+0.8 (+4.21%)

, AMWL

Amwell

$3.82 /

-0.13 (-3.29%)

, ANGO

AngioDynamics

$23.05 /

-0.91 (-3.80%)

, AVNS

Avanos

$32.09 /

-0.415 (-1.28%)

, AVTR

Avantor

$34.49 /

-0.655 (-1.86%)

, AZTA

Azenta

$86.50 /

-0.82 (-0.94%)

, BLFS

BioLife Solutions

$22.98 /

-1.63 (-6.62%)

, CSTL

Castle Biosciences

$43.62 /

-1.41 (-3.13%)

, EBS

Emergent BioSolutions

$41.42 /

-1.5 (-3.49%)

, ENZ

Enzo Biochem

$3.00 /

-0.08 (-2.60%)

, EVH

Evolent Health

$31.34 /

+0.495 (+1.60%)

, ICUI

ICU Medical

$247.68 /

+2.9 (+1.18%)

, INGN

Inogen

$33.42 /

+0.15 (+0.45%)

, IVC

Invacare

$1.59 /

-0.13 (-7.56%)

, LMAT

LeMaitre

$44.15 /

-1.91 (-4.15%)

, MRVI

Maravai Lifesciences

$38.50 /

-2.28 (-5.59%)

, NXGN

NextGen Healthcare

$20.16 /

+0.35 (+1.77%)

, PINC

Premier

$35.85 /

-0.51 (-1.40%)

, TFX

Teleflex

$349.16 /

-1.02 (-0.29%)

, WST

West Pharmaceutical

$412.49 /

-1.72 (-0.42%)

, XGN

Exagen

$8.15 /

-0.33 (-3.89%)

Life Sciences &…

Life Sciences & MedTech Virtual Forum to be held on March 22-23.

ShowHide Related Items >><<
XGN Exagen
$8.15 /

-0.33 (-3.89%)

WST West Pharmaceutical
$412.49 /

-1.72 (-0.42%)

TFX Teleflex
$349.16 /

-1.02 (-0.29%)

PINC Premier
$35.85 /

-0.51 (-1.40%)

NXGN NextGen Healthcare
$20.16 /

+0.35 (+1.77%)

MRVI Maravai Lifesciences
$38.50 /

-2.28 (-5.59%)

LMAT LeMaitre
$44.15 /

-1.91 (-4.15%)

IVC Invacare
$1.59 /

-0.13 (-7.56%)

INGN Inogen
$33.42 /

+0.15 (+0.45%)

EVH Evolent Health
$31.34 /

+0.495 (+1.60%)

ENZ Enzo Biochem
$3.00 /

-0.08 (-2.60%)

EBS Emergent BioSolutions
$41.42 /

-1.5 (-3.49%)

CSTL Castle Biosciences
$43.62 /

-1.41 (-3.13%)

BLFS BioLife Solutions
$22.98 /

-1.63 (-6.62%)

AZTA Azenta
$86.50 /

-0.82 (-0.94%)

AVTR Avantor
$34.49 /

-0.655 (-1.86%)

AVNS Avanos
$32.09 /

-0.415 (-1.28%)

ANGO AngioDynamics
$23.05 /

-0.91 (-3.80%)

AMWL Amwell
$3.82 /

-0.13 (-3.29%)

AGTI Agiliti
$19.82 /

+0.8 (+4.21%)

03/09/22 Citi
Agiliti price target lowered to $25 from $28 at Citi
01/10/22 Citi
Agiliti assumed with a Buy at Citi
08/16/21 Citi
Citi says Agiliti selloff overdone, boosts target to $22
05/26/21 BMO Capital
Agiliti price target raised to $26 from $18 at BMO Capital
AMWL Amwell
$3.82 /

-0.13 (-3.29%)

02/25/22 Piper Sandler
Amwell price target lowered to $7 from $12 at Piper Sandler
02/11/22 Goldman Sachs
Amwell initiated with a Neutral at Goldman Sachs
12/01/21 Jefferies
Amwell initiated with a Hold at Jefferies
11/22/21 Piper Sandler
Piper remains buyer of Amwell despite chat supporting below consensus FY22 view
ANGO AngioDynamics
$23.05 /

-0.91 (-3.80%)

01/07/22 Canaccord
AngioDynamics price target lowered to $34 from $37 at Canaccord
10/15/21
Fly Intel: Top five analyst upgrades
10/15/21 Canaccord
AngioDynamics upgraded to Buy at Canaccord on future growth clarity
10/15/21 Canaccord
AngioDynamics upgraded to Buy from Hold at Canaccord
AVNS Avanos
$32.09 /

-0.415 (-1.28%)

02/24/22 KeyBanc
Avanos price target lowered to $41 from $47 at KeyBanc
08/04/21 KeyBanc
Avanos price target lowered to $47 from $55 at KeyBanc
08/04/21 Stephens
Avanos downgraded to Equal Weight from Overweight at Stephens
AVTR Avantor
$34.49 /

-0.655 (-1.86%)

02/07/22 Raymond James
Avantor price target lowered to $43 from $47 at Raymond James
02/07/22 Baird
Avantor price target lowered to $43 from $44 at Baird
02/07/22 Barclays
Avantor price target raised to $44 from $41 at Barclays
01/27/22 Barclays
Avantor price target lowered to $41 from $48 at Barclays
AZTA Azenta
$86.50 /

-0.82 (-0.94%)

03/21/22 Evercore ISI
Azenta initiated with an Outperform at Evercore ISI
02/09/22 Needham
Azenta price target lowered to $115 from $155 at Needham
11/17/21 Stifel
Brooks Automation price target raised to $149 from $134 at Stifel
11/17/21 Stephens
Brooks Automation price target raised to $137 from $130 at Stephens
BLFS BioLife Solutions
$22.98 /

-1.63 (-6.62%)

03/02/22 B. Riley
BioLife Solutions price target lowered to $48 from $67 at B. Riley
01/03/22 Stephens
Wendy's, Kirby and Vizio among Stephens' 2022 Best Ideas
12/31/21 Northland
BioLife Solutions named a top pick for 2022 at Northland
10/19/21 B. Riley
BioLife Solutions transferred with Buy, $61 target at B. Riley
CSTL Castle Biosciences
$43.62 /

-1.41 (-3.13%)

03/01/22 Lake Street
Castle Biosciences price target lowered to $63 from $94 at Lake Street
03/01/22 Baird
Castle Biosciences price target lowered to $60 from $82 at Baird
01/06/22 Stephens
Stephens starts skin cancer test leader Castle Biosciences at Overweight
01/06/22 Stephens
Castle Biosciences initiated with an Overweight at Stephens
EBS Emergent BioSolutions
$41.42 /

-1.5 (-3.49%)

01/20/22 Cantor Fitzgerald
Emergent BioSolutions price target raised to $55 from $50 at Cantor Fitzgerald
01/20/22 Benchmark
Emergent BioSolutions upgraded to Buy from Hold at Benchmark
12/27/21 Cowen
Emergent's Narcan sales under immediate threat, says Cowen
11/10/21 Chardan
Emergent BioSolutions price target lowered to $75 from $92 at Chardan
ENZ Enzo Biochem
$3.00 /

-0.08 (-2.60%)

EVH Evolent Health
$31.34 /

+0.495 (+1.60%)

03/08/22 Cowen
Evolent Health remains top pick after meeting with management, says Cowen
03/07/22 Piper Sandler
Evolent Health news removes $82M overhang, says Piper Sandler
03/04/22 Piper Sandler
Bright Health expansion big revenue opportunity for Evolent, says Piper
02/24/22 Piper Sandler
Evolent Health price target lowered to $32 from $36 at Piper Sandler
ICUI ICU Medical
$247.68 /

+2.9 (+1.18%)

09/09/21 Raymond James
ICU Medical price target raised to $286 from $220 at Raymond James
INGN Inogen
$33.42 /

+0.15 (+0.45%)

12/09/21 Needham
Inogen upgraded to Buy from Hold at Needham
12/09/21 Needham
Inogen upgraded to Buy from Hold at Needham
11/02/21
Fly Intel: Top five analyst upgrades
11/02/21 JPMorgan
Inogen upgraded to Neutral with risks priced in at JPMorgan
IVC Invacare
$1.59 /

-0.13 (-7.56%)

09/10/21 Needham
Invacare price target lowered to $8 from $17 at Needham
08/19/21 Oppenheimer
Invacare initiated with an Outperform at Oppenheimer
LMAT LeMaitre
$44.15 /

-1.91 (-4.15%)

02/25/22 Barrington
LeMaitre price target lowered to $54 from $62 at Barrington
09/16/21
Fly Intel: Top five analyst initiations
09/16/21 Jefferies
Jefferies starts LeMaitre at Buy on ArteGraft upside potential
09/16/21 Jefferies
LeMaitre initiated with a Buy at Jefferies
MRVI Maravai Lifesciences
$38.50 /

-2.28 (-5.59%)

02/28/22 William Blair
Maravai buyout price would need to be well into $50s, says William Blair
02/24/22 Baird
Maravai Lifesciences price target lowered to $48 from $60 at Baird
10/01/21 Morgan Stanley
Maravai selloff on Merck's molnupiravir data overdone, says Morgan Stanley
08/11/21 Credit Suisse
Maravai Lifesciences price target raised to $54 from $44 at Credit Suisse
NXGN NextGen Healthcare
$20.16 /

+0.35 (+1.77%)

01/26/22 Piper Sandler
NextGen Healthcare price target raised to $24 from $23 at Piper Sandler
01/06/22 SVB Securities
SVB Leerink upgrades NextGen Healthcare to Outperform with $22 price target
01/06/22 SVB Securities
NextGen Healthcare upgraded to Outperform from Market Perform at SVB Leerink
01/05/22 Piper Sandler
NextGen Healthcare named a 2022 top pick at Piper Sandler
PINC Premier
$35.85 /

-0.51 (-1.40%)

11/18/21 Barclays
Premier price target raised to $36 from $34 at Barclays
11/03/21 Piper Sandler
Premier price target raised to $39 from $31 at Piper Sandler
05/28/21
Fly Intel: Top five analyst downgrades
05/28/21 Barclays
Barclays double downgrades Premier with multiple expansion less likely
TFX Teleflex
$349.16 /

-1.02 (-0.29%)

02/24/22 Piper Sandler
Teleflex price target raised to $335 from $320 at Piper Sandler
01/21/22 Piper Sandler
Teleflex price target lowered to $320 from $325 at Piper Sandler
01/07/22 Morgan Stanley
Teleflex cut to Equal Weight at Morgan Stanley on near-term UroLift caution
01/07/22 Morgan Stanley
Teleflex downgraded to Equal Weight from Overweight at Morgan Stanley
WST West Pharmaceutical
$412.49 /

-1.72 (-0.42%)

XGN Exagen
$8.15 /

-0.33 (-3.89%)

10/14/21 Cowen
Exagen coverage transferred at Cowen
08/10/21 BTIG
Exagen price target lowered to $20 from $23 at BTIG
04/15/21
Fly Intel: Top five analyst initiations
04/15/21 Canaccord
Canaccord starts Exagen at Buy, sees 50% upside potential
XGN Exagen
$8.15 /

-0.33 (-3.89%)

WST West Pharmaceutical
$412.49 /

-1.72 (-0.42%)

TFX Teleflex
$349.16 /

-1.02 (-0.29%)

PINC Premier
$35.85 /

-0.51 (-1.40%)

NXGN NextGen Healthcare
$20.16 /

+0.35 (+1.77%)

MRVI Maravai Lifesciences
$38.50 /

-2.28 (-5.59%)

LMAT LeMaitre
$44.15 /

-1.91 (-4.15%)

IVC Invacare
$1.59 /

-0.13 (-7.56%)

INGN Inogen
$33.42 /

+0.15 (+0.45%)

ICUI ICU Medical
$247.68 /

+2.9 (+1.18%)

EVH Evolent Health
$31.34 /

+0.495 (+1.60%)

ENZ Enzo Biochem
$3.00 /

-0.08 (-2.60%)

EBS Emergent BioSolutions
$41.42 /

-1.5 (-3.49%)

CSTL Castle Biosciences
$43.62 /

-1.41 (-3.13%)

BLFS BioLife Solutions
$22.98 /

-1.63 (-6.62%)

AZTA Azenta
$86.50 /

-0.82 (-0.94%)

AVTR Avantor
$34.49 /

-0.655 (-1.86%)

AVNS Avanos
$32.09 /

-0.415 (-1.28%)

ANGO AngioDynamics
$23.05 /

-0.91 (-3.80%)

AMWL Amwell
$3.82 /

-0.13 (-3.29%)

AGTI Agiliti
$19.82 /

+0.8 (+4.21%)

  • 14
    Sep
  • 10
    Sep
  • 14
    Jul
  • 23
    Apr
  • 08
    Apr
  • 23
    Mar
MRVI Maravai Lifesciences
$38.50 /

-2.28 (-5.59%)

EVH Evolent Health
$31.34 /

+0.495 (+1.60%)

EBS Emergent BioSolutions
$41.42 /

-1.5 (-3.49%)

AMWL Amwell
$3.82 /

-0.13 (-3.29%)

TFX Teleflex
$349.16 /

-1.02 (-0.29%)

MRVI Maravai Lifesciences
$38.50 /

-2.28 (-5.59%)

EVH Evolent Health
$31.34 /

+0.495 (+1.60%)

EBS Emergent BioSolutions
$41.42 /

-1.5 (-3.49%)

BLFS BioLife Solutions
$22.98 /

-1.63 (-6.62%)

AZTA Azenta
$86.50 /

-0.82 (-0.94%)

AVTR Avantor
$34.49 /

-0.655 (-1.86%)

ANGO AngioDynamics
$23.05 /

-0.91 (-3.80%)

AMWL Amwell
$3.82 /

-0.13 (-3.29%)

AGTI Agiliti
$19.82 /

+0.8 (+4.21%)

WST West Pharmaceutical
$412.49 /

-1.72 (-0.42%)

IVC Invacare
$1.59 /

-0.13 (-7.56%)

ENZ Enzo Biochem
$3.00 /

-0.08 (-2.60%)

AZTA Azenta
$86.50 /

-0.82 (-0.94%)

AMWL Amwell
$3.82 /

-0.13 (-3.29%)

Recommendations
Avanos price target lowered to $41 from $47 at KeyBanc » 07:24
02/24/22
02/24
07:24
02/24/22
07:24
AVNS

Avanos

$31.74 /

+2.18 (+7.37%)

KeyBanc analyst Matthew…

KeyBanc analyst Matthew Mishan lowered the firm's price target on Avanos to $41 from $47 to reflect a change in valuation methodology, while keeping an Overweight rating on the shares. The analyst continues to view risk/reward favorably, and its initial outlook for 2022 appeared generally consistent with expectations in context of the current environment.

ShowHide Related Items >><<
AVNS Avanos
$31.74 /

+2.18 (+7.37%)

AVNS Avanos
$31.74 /

+2.18 (+7.37%)

08/04/21 KeyBanc
Avanos price target lowered to $47 from $55 at KeyBanc
08/04/21 Stephens
Avanos downgraded to Equal Weight from Overweight at Stephens
AVNS Avanos
$31.74 /

+2.18 (+7.37%)

Earnings
Avanos sees 2022 adjusted EPS $1.55-$1.75, consensus $1.52 » 07:03
02/23/22
02/23
07:03
02/23/22
07:03
AVNS

Avanos

$29.55 /

+0.69 (+2.39%)

Sees 2022 revenue…

Sees 2022 revenue $830M-$850M, consensus $780.32M. Each of these measures is inclusive of the impact of the OrthogenRx acquisition and assumes that supply chain headwinds related to both product availability and inflation pressures, will continue well into 2022.

ShowHide Related Items >><<
AVNS Avanos
$29.55 /

+0.69 (+2.39%)

AVNS Avanos
$29.55 /

+0.69 (+2.39%)

08/04/21 KeyBanc
Avanos price target lowered to $47 from $55 at KeyBanc
08/04/21 Stephens
Avanos downgraded to Equal Weight from Overweight at Stephens
AVNS Avanos
$29.55 /

+0.69 (+2.39%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.